Renaissance Technologies (RenTech)'s BOLT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 77,225 shares of Bolt Biotherapeutics, Inc. (BOLT) worth $311,989, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in BOLT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 26,400 shares. Largest reduction occurred in Q2 2024, reducing 12,045 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Bolt Biotherapeutics (BOLT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bolt Biotherapeutics (BOLT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +22,200 | Add 40.35% | 77,225 | $4.04 |
| Q4 2025 | +26,400 | Add 92.23% | 55,025 | $5.47 |
| Q3 2025 | +10,300 | Add 56.21% | 28,625 | $5.32 |
| Q2 2025 | +2,618 | Add 16.67% | 18,325 | $5.77 |
| Q1 2025 | +605 | Add 4.01% | 15,707 | $8.00 |
| Q4 2024 | +400 | Add 2.72% | 15,102 | $10.70 |
| Q3 2024 | +865 | Add 6.25% | 14,702 | $12.96 |
| Q2 2024 | -12,045 | Reduce 46.54% | 13,837 | $15.00 |
| Q1 2024 | +3,618 | Add 16.25% | 25,882 | $28.01 |
| Q4 2023 | +6,555 | Add 41.73% | 22,264 | $22.41 |
| Q3 2023 | -8,488 | Reduce 35.08% | 15,709 | $20.82 |
| Q2 2023 | +1,360 | Add 5.96% | 24,197 | $0.03 |
| Q1 2023 | +760 | Add 3.44% | 22,837 | $0.03 |
| Q4 2022 | +2,384 | Add 12.11% | 22,077 | $0.03 |
| Q3 2022 | -7,236 | Reduce 26.87% | 19,693 | $29.60 |
| Q2 2022 | +12,424 | Add 85.65% | 26,929 | $40.81 |
| Q1 2022 | +10,060 | Add 226.32% | 14,505 | $54.81 |
| Q4 2021 | +480 | Add 12.11% | 4,445 | $98.09 |
| Q3 2021 | +941 | Add 31.12% | 3,965 | $252.96 |
| Q2 2021 | +3,024 | New Buy | 3,024 | $309.19 |
Renaissance Technologies (RenTech)'s Bolt Biotherapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Bolt Biotherapeutics, Inc. (BOLT) in Q2 2021, acquiring 3,024 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Bolt Biotherapeutics, Inc. (BOLT) for 20 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Bolt Biotherapeutics, Inc. (BOLT) was in Q4 2025, adding 55,025 shares worth $300,877.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 77,225 shares of Bolt Biotherapeutics, Inc. (BOLT), valued at approximately $311,989.
As of the Q1 2026 filing, Bolt Biotherapeutics, Inc. (BOLT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Bolt Biotherapeutics, Inc. (BOLT) was 77,225 shares, as reported at the end of Q1 2026.